The Spring Myeloma Today Edition has articles on the FDA’s approval of CARVYKTI™ CAR T-cell therapy, 2022 Brian D. Novis Research Grants, Bispecific Antibodies in Myeloma and more!
Download a Copy | Subscribe to Myeloma Today
